Cargando…

New methods for the diagnosis and monitoring of cognitive function in patients with type 2 diabetes

The presence of type 2 diabetes acts as an accelerator of cognitive impairment (mild cognitive impairment and later dementia), with a significant impact on the management of the disease and its complications. Therefore, it is recommended to perform an annual evaluation of cognitive function in patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciudin, Andreea, Simó, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751391/ https://www.ncbi.nlm.nih.gov/pubmed/36531450 http://dx.doi.org/10.3389/fendo.2022.1024794

Ejemplares similares

The Gaze Fixation Assessed by Microperimetry: A Useful Tool for the Monitoring of the Cognitive Function in Patients with Type 2 Diabetes
por: Ortiz-Zúñiga, Ángel Michael, et al.
Publicado: (2021)

Comparison of computed tomography and dual-energy X-ray absorptiometry in the evaluation of body composition in patients with obesity
por: Palmas, Fiorella, et al.
Publicado: (2023)

Characterization of Sleep Breathing Pattern in Patients with Type 2 Diabetes: Sweet Sleep Study
por: Lecube, Albert, et al.
Publicado: (2015)

Usefulness of Eye Fixation Assessment for Identifying Type 2 Diabetic Subjects at Risk of Dementia
por: Simó-Servat, Olga, et al.
Publicado: (2019)

Molecular Implications of the PPARs in the Diabetic Eye
por: Ciudin, Andreea, et al.
Publicado: (2013)

Iron Overload in Diabetic Retinopathy: A Cause or a Consequence of Impaired Mechanisms?
por: Ciudin, Andreea, et al.
Publicado: (2010)

Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study
por: Bañares, Juan, et al.
Publicado: (2022)

Prevalence and risk factors accounting for true silent myocardial ischemia: a pilot case-control study comparing type 2 diabetic with non-diabetic control subjects
por: Hernández, Cristina, et al.
Publicado: (2011)

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain
por: Ortiz Zuñiga, Angel Michael, et al.
Publicado: (2020)

Obesity is associated with greater cognitive function in patients with type 2 diabetes mellitus
por: Xing, Zhenhua, et al.
Publicado: (2022)

Assessment of dyspneic sensation in patients with type 2 diabetes
por: Mizab, Chadia, et al.
Publicado: (2023)

The Footprint of Type 1 Diabetes on Red Blood Cells: A Metabolomic and Lipidomic Study
por: Herance, José Raul, et al.
Publicado: (2023)

Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes
por: López-Cano, Carolina, et al.
Publicado: (2019)

Monitoring of Pediatric Type 1 Diabetes
por: Marks, Brynn E., et al.
Publicado: (2020)

New biomarkers: prospect for diagnosis and monitoring of thyroid disease
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

Aberrant Functional Connectivity of the Posterior Cingulate Cortex in Type 2 Diabetes Without Cognitive Impairment and Microvascular Complications
por: Cheng, Panpan, et al.
Publicado: (2021)

The Association of Hypoglycemia Assessed by Continuous Glucose Monitoring With Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes
por: Wei, Wei, et al.
Publicado: (2019)

Increased Glycemic Variability Evaluated by Continuous Glucose Monitoring is Associated with Osteoporosis in Type 2 Diabetic Patients
por: Huang, Rong, et al.
Publicado: (2022)

New insights from monogenic diabetes for “common” type 2 diabetes
por: Tallapragada, Divya Sri Priyanka, et al.
Publicado: (2015)

Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial
por: Zimering, Mark B., et al.
Publicado: (2016)

Variables Involved in the Discordance between HbA1c and Fructosamine: The Glycation Gap Revisited
por: Zafon, Carles, et al.
Publicado: (2013)

A Translational In Vivo and In Vitro Metabolomic Study Reveals Altered Metabolic Pathways in Red Blood Cells of Type 2 Diabetes
por: Palomino-Schätzlein, Martina, et al.
Publicado: (2020)

Impact of glucagon-like peptide 1 analogs on cognitive function among patients with type 2 diabetes mellitus: A systematic review and meta−analysis
por: Luan, Sisi, et al.
Publicado: (2022)

Interhemispheric asymmetry of the brain in patients with type 1 diabetes mellitus and cognitive impairment
por: Samoilova, Yulia Gennadevna, et al.
Publicado: (2022)

Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction
por: Chakraborty, Arpita, et al.
Publicado: (2021)

Risk Assessment of Sarcopenia in Patients With Type 2 Diabetes Mellitus Using Data Mining Methods
por: Cui, Mengzhao, et al.
Publicado: (2020)

Global Assessment of the Impact of Type 2 Diabetes on Sleep through Specific Questionnaires. A Case-Control Study
por: Lecube, Albert, et al.
Publicado: (2016)

Progranulin and Its Receptor Predict Kidney Function Decline in Patients With Type 2 Diabetes
por: Murakoshi, Maki, et al.
Publicado: (2022)

Is the level of serum lactate dehydrogenase a potential biomarker for glucose monitoring with type 2 diabetes mellitus?
por: Hsieh, Yu-Shan, et al.
Publicado: (2022)

The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes
por: Yuan, Yanping, et al.
Publicado: (2023)

Altered dynamic functional architecture in type 2 diabetes mellitus
por: Li, Yifan, et al.
Publicado: (2023)

Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study
por: Lu, Lanyu, et al.
Publicado: (2023)

The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention
por: Vinik, Aaron I., et al.
Publicado: (2015)

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
por: John, Mathew, et al.
Publicado: (2016)

Inherited Real Risk of Type 2 Diabetes Mellitus: bedside diagnosis, pathophysiology and primary prevention
por: Stagnaro, Sergio, et al.
Publicado: (2013)

The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes
por: Zhang, Deyuan, et al.
Publicado: (2019)

A new predictive model for the concurrent risk of diabetic retinopathy in type 2 diabetes patients and the effect of metformin on amino acids
por: Song, Zicheng, et al.
Publicado: (2022)

Commentary: Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial
por: Brož, Jan, et al.
Publicado: (2018)

The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review
por: Bennetsen, Sebastian L., et al.
Publicado: (2020)

Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy
por: Yan, Reng-na, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sj01jcpith9h1g7nou43ur21c2